Promising TB therapy safe for patients with HIV

Texas Biomed researchers complete critical preclinical study to advance potential tuberculosis therapy toward human clinical trials

2024-10-01

(Press-News.org) SAN ANTONIO (October 1, 2024) – A therapy showing promise to help control tuberculosis (TB) does not interfere with combined antiretroviral therapy (cART), according to research by Texas Biomedical Research Institute (Texas Biomed).

“This is an important hurdle that this host-directed therapy had to clear in order to help patients battling both HIV and TB,” said Texas Biomed Professor Smriti Mehra, Ph.D., who led the study recently published in the peer-reviewed journal JCI Insight.

TB is responsible for more than 1.3 million deaths worldwide every year. Dr. Mehra and her team have been investigating a therapy currently used in cancer as a potential treatment for patients with drug-resistant TB and/or comorbid HIV. While many cases of TB can be controlled with months of antibiotics, the infection can return in people who are immunocompromised as a result of HIV. Now that cART is so effective at controlling HIV, a resurging TB infection can often be deadly to those individuals.

Dr. Mehra is studying a host-directed therapy that blocks or inhibits an immune system protein naturally found in the body. The protein, called IDO (short for Indoleamine-2,3-dioxygenase), normally suppresses the immune system, preventing it from causing excessive inflammation and organ damage. Inhibiting IDO for short intervals of time has led to more successful cancer treatments. Dr. Mehra’s team has previously shown the same approach improves control of TB in conjunction with antibiotics.

This current study in nonhuman primates with both TB and simian immunodeficiency virus, the nonhuman primate version of HIV, showed the IDO inhibitor does not interfere with cART.

“There was no increase in viral load in animals given cART and the IDO inhibitor, compared with animals only given cART, proving the inhibitor is safe to give to patients with HIV,” Dr. Mehra said.

Now that the researchers have shown the inhibitor works well in conjunction with TB antibiotics and with cART separately, they plan to study how it performs when given in conjunction with both antibiotics and cART together. This treatment regimen is standard for patients with both HIV and active TB. Dr. Mehra said that longer-term studies are also needed to confirm there are no unintended side effects.

The IDO inhibitor is already FDA-approved for use in patients with cancer, which shortens the path to potential approval for patients with TB/HIV when compared with developing a brand-new drug.

###

About Texas Biomed

Texas Biomed is a nonprofit research institute dedicated to protecting the global community from infectious diseases. Through basic research, preclinical testing and innovative partnerships, we accelerate diagnostics, therapies and vaccines for the world’s deadliest pathogens. Our San Antonio campus hosts high containment laboratories and the Southwest National Primate Research Center. Our scientists collaborate with industry and researchers globally, and have helped deliver the first COVID-19 vaccine, the first Ebola treatment and first Hepatitis C therapy.

END

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

American Academy of Pediatrics examines the impact of school expulsion and recommends ways to create supportive learning environments for all students

2024-10-01

Media Contacts: Alex Hulvalchick, 630-626-6282 Lisa Robinson, 630-626-6084, lrobinson@aap.org American Academy of Pediatrics Examines the Impact of School Expulsion and Recommends Ways to Create Supportive Learning Environments for All Students Updated policy statement on school suspension to be released during the AAP 2024 National Conference & Exhibition in Orlando. ORLANDO, Fla.--Suspending or expelling a student is one of the most severe punishments a school can impose on a student – and it can have lifelong, devastating consequences. ...

Most pregnant people got vaccinated for COVID-19 in 2022

2024-10-01

A study of more than 28,000 pregnancies from 2022 has found that the majority of pregnant people received the COVID-19 vaccine during its initial release. The study, co-led by McMaster University and the University of British Columbia, used data from ICES, an independent, not-for-profit research institute, to provide insight into vaccination rates among one of the groups most vulnerable to health complications caused by COVID-19. The research, published in the Canadian Medical Association Journal (CMAJ) ...

Coral reef destruction a threat to human rights

2024-10-01

A human rights-based approach to coral reef protection could ensure governments are held to account for safeguarding marine ecosystems and empower local and Indigenous communities to demand sustainable solutions and climate justice, a new study suggests. An estimated one billion people rely on healthy coral reefs globally for food security, coastal protection and income from tourism and other services. If reefs and their ecosystems are lost, the impact on human health and economic wellbeing would be catastrophic. Lead ...

Tongan volcanic eruption triggered by explosion as big as ‘five underground nuclear bombs’

2024-10-01

The Hunga Tonga underwater volcano was one of the largest volcanic eruptions in history, and now, two years later, new research from The Australian National University (ANU) has revealed its main trigger. Until now, the cause of the cataclysmic event has remained largely a mystery to the scientific community, yet a student-led team of ANU seismologists has been able to shed new light on the natural explosion that initiated the event. The student researchers analysed the climactic event’s noisy but valuable seismic ...

Syrian hamsters reveal genetic secret to hibernation

2024-10-01

A gene that limits cellular damage could be the key to surviving prolonged cold exposure. Researchers have identified a gene that enables mammalian cells to survive for long periods at extremely low temperature, which animals experience during hibernation. Body temperatures below 10 degrees Celsius (°C) swiftly prove fatal for humans and many other mammals, because prolonged cold stress causes cells to accumulate damaging free radicals—in particular lipid peroxide radicals—resulting in cell death and organ failure. But a few mammalian species can survive cold stress by hibernating. Hibernation in many small mammals involves ...

Tracking microplastics: FAMU-FSU College of Engineering researcher helps discover how microplastics move for better storm water management

2024-10-01

Microplastic pollution is a significant environmental problem that harms animals and people and affects ecosystems worldwide. These tiny pieces of plastic, smaller than five millimeters, are pushed by wind and water to move around the globe. Nasrin Alamdari, an assistant professor in the FAMU-FSU College of Engineering’s Department of Civil and Environmental Engineering, is on a mission to learn more about microplastics and how they move. In research published in Environmental Pollution, she helped examine how shape, size and density affect the speed at which ...

The Lancet Psychiatry: Conversion practice linked to greater risk of mental health symptoms, surveys of LGBTQ+ people in the USA suggest

2024-09-30

Analysis of questionnaires completed by 4,426 LGBTQ+ people in the USA suggests undergoing conversion practice targeting gender identity or sexual orientation is linked with symptoms of depression, PTSD and suicidal thoughts or attempts. Cisgender and transgender participants also had more severe symptoms of depression and PTSD if they had undergone conversion practice. Cisgender participants subjected to both types of conversion practice had a greater risk of suicidal thoughts and attempts than transgender participants – but mental health symptoms were more severe for transgender people overall, ...

Most accurate ultrasound test could detect 96% of women with ovarian cancer

2024-09-30

An ultrasound test that detected 96% of ovarian cancers in postmenopausal women should replace current standard of care test in the UK according to a new study. In a paper published in Lancet Oncology today (Monday 30 September), research funded by the National Institute for Health and Care Research (NIHR) and led by Professor Sudha Sundar from the University of Birmingham compared all currently available tests to diagnose ovarian cancer in postmenopausal women head-to-head in a high-quality diagnostic test accuracy study. Of the six diagnostic tests investigated, ...

Sylvester study: MRI provides early warning system for glioblastoma growth

2024-09-30

MIAMI, FLORIDA (EMBARGOED UNTIL SEPT. 30, 2024, AT 5:40 P.M. EDT) – A new study shows the potential power of imaging paired with radiation to shape treatment for glioblastoma patients in real time. The study, led by researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, is the first to quantify tumor changes in glioblastoma patients receiving MRI-guided radiation therapy. This novel technique, also known as MRI-linear accelerator or MRI-linac, pairs ...

Making soybeans smarter

2024-09-30

Ron Mittler is on a quest to create a smarter soybean. For years, mid-Missouri has withstood unpredictable weather patterns, including drought, heat waves and flooding — conditions that are known to hamper agricultural yields and make it difficult for farmers to produce. While we can’t control the weather, Mittler and his team are working to harness soybean crops’ natural ability to adapt to unfavorable weather conditions while also increasing their yields. Working with $2.4 million from ...

Promising TB therapy safe for patients with HIV

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: